2.18
price up icon0.93%   0.02
after-market Handel nachbörslich: 2.16 -0.02 -0.92%
loading

Finanzdaten der In 8 Bio Inc-Aktie (INAB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
125.15%
0.083
-0.33 - - 0.33
Operating Expenses
13.78%
8.645
7.598 7.169 7.715 7.855
Benefits Costs and Expenses
8.645
- 7.169 7.715 7.855
Costs And Expenses
8.645
- 7.169 7.715 7.855
Operating Income/Loss
8.00%
-8.562
-7.928 -7.169 -7.715 -7.525
Income/Loss From Continuing Operations Before Tax
35.81%
-8.562
-13.34 -7.169 -7.715 -7.525
Income/Loss From Continuing Operations After Tax
12.69%
-8.562
-7.598 -7.169 -7.715 -7.525
Net Income/Loss
12.69%
-8.562
-7.598 -7.169 -7.715 -7.525
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,623%
43.29
1.5897 31.55 28.47 24.73
Diluted Average Shares
2,623%
43.29
1.5897 31.55 28.47 24.73
Basic Earnings Per Share
4.76%
-0.20
-0.21 -0.23 -0.27 -0.30
Diluted Earnings Per Share
4.76%
-0.20
-0.21 -0.23 -0.27 -0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Kapitalisierung:     |  Volumen (24h):